Monday, March 18, 2024 7:01:20 PM
OK, well, let's take a look at that so-called "truth" from some of KBLB's PRs over the years:
- How about the PR that (falsely) stated that they were going to make their 1st delivery around Oct 16, 2022?
- How about the PR that (falsely) claimed that they were going to launch the "Spydasilk website and brand" in "the coming weeks"?
- How about the PR that (falsely) stated that they were in commercial production back in 2013?
- How about the PRs that (falsely) claimed that they were going to deliver shootpacks and 100 kgs of custom spidersilk to the Army, and then never delivered anything promised?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162383919
- How about the PR that (falsely) claimed that they would be "featured" in a French documentary on combating terrorism in Fall 2019 (but they never were)?
- How about the PRs that (falsely) stated that they would be seating new (independent) board members by the end of 2019 (but never did)?
- How about the PRs that (falsely) stated that they were going to be in commercial production at the end of 2019 / start of 2020?
- How about the PR that (falsely) claimed that they would be producing over 8 metric tons in 2020?
- How about the PR that (falsely) stated that they were going to receive $250K in 2021?
- How about the PR that (falsely) stated that the scumbag CEO was going to speak at the SynBio Markets Conference in Mar 2021
- How about the PRs that (falsely) insinuate that they have patents, when in fact they don't even have ONE?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162548521
It is painfully obvious that the PRs do tell the truth about KBLB, and it isn't pretty...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM